Live Breaking News & Updates on Yung Shun Wen

Stay updated with breaking news from Yung shun wen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000

Single-ascending-dose (SAD) study successfully demonstrated the safety, tolerability, and sustained release profile at least 3 months resulting from ALA-1000 injection in patients with opioid dependence. TAICHUNG, Taiwan, Jan. 13, 2022 /PRNewswire/ Alar Pharmaceuticals Inc. (Alar, TWSE:6785), a clinical-stage biopharmaceutical company focused on developing long-acting injectables (LAIs) for central nervous system disorders, announces the completion and positive results. ....

Charles Lin , Prnewswire Alar Pharmaceuticals Inc , Dalar Pharmaceuticals , Clinical Opiate Withdrawal Scale , Opioid Craving Visual Analog Scale , Yung Shun Wen ,

Rompre le cycle de la dépendance aux opioïdes : Alar présente les résultats intermédiaires positifs de la buprénorphine injectable à action prolongée (ALA-1000) chez les patients dépendants aux opioïdes

Rompre le cycle de la dépendance aux opioïdes : Alar présente les résultats intermédiaires positifs de la buprénorphine injectable à action prolongée (ALA-1000) chez les patients dépendants aux opioïdes
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Links To Related Source Alar Pharmaceuticals , Dalar Pharmaceuticals , Alar Pharmaceuticals Inc , Dalar Pharmaceuticals , Yung Shun Wen , American Fda , D Alar Pharmaceuticals , Pharmaceuticals Inc , Following Links , Related Source Alar Pharmaceuticals , Oran To Launch The New Republic , ஒன்றுபட்டது மாநிலங்களில் , அலார் மருந்துகள் , அலார் மருந்துகள் இன்க் , மருந்துகள் இன்க் ,